MNOV compared with TELA: revenue, margins and what each company keeps, and the suppliers and customers both name

MNOVMedicinova Inc

Mkt capRevenueRevenue

TELATELA Bio, Inc.

Mkt capRevenueRevenue

Compare

MNOVMedicinova Inc

TELATELA Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MNOV: latest quarter is a loss; flow not drawable. TELA: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

MNOV, solidTELA, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MNOV 0

None

Shared 0

No disclosed counterparties: MNOV.

Only TELA 4

—Aroa Biosurgeryunlistedsupplier

—Advanced Medical Solutionsunlistedsupplier

—Aroaunlistedsupplier

—MiMedxunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

MNOVMedicinova Inc

1.46▲+4.29%· post 1.42

Mkt cap$68.9MRevenue$458,439Q2 FY26Revenue—

TELATELA Bio, Inc.

0.86▼−7.07%· post 0.81

ClosedOct 30 '26

Mkt cap$36.4MRevenue$19MQ2 FY26Revenue$80MFY25

Compare

ClosedOct 30 '26

MNOVMedicinova Inc

TELATELA Bio, Inc.

1.46▲+4.29%post 1.42

Price

0.86▼−7.07%post 0.81

$68.9M

Mkt cap

$36.4M

Q2 FY26$458,439

Revenue

$19MQ2 FY26

—

Revenue

$80MFY25

MNOV1.46▲+4.29%vsTELA0.86▼−7.07%ClosedOct 30 '26